« on: July 16, 2019, 06:26:59 pm »
It's not a dopamine agonist, but PT-141 was recently approved by the FDA for treating low libido in women.
This is of interest to ME. Not so sure for my wife.
TRT has done nothing so far for her libido. Although her free T has not come up past the ministry threshold they list for women. And part of my wife's issue with libido may be more mental than physiological. If the driver doesn’t really want to drive to a destination, it doesn’t matter how much fuel is in the tank!
What is PT-141?
FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women
The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Vyleesi activates melanocortin receptors, but the mechanism by which it improves sexual desire and related distress is unknown. Patients inject Vyleesi under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity and may decide the optimal time to use Vyleesi based on how they experience the duration of benefit and any side effects, such as nausea. Patients should not use more than one dose within 24 hours or more than eight doses per month. Patients should discontinue treatment after eight weeks if they do not report an improvement in sexual desire and associated distress.
It works for guys too.